Correction to: Oncogenesis https://doi.org/10.1038/oncsis.2017.8, published online 13 March 2017
Following the publication of this article the authors noted that an incorrect image had been presented in Fig. 5c. The correct lower image of intracranial brain tumor of SW1088/Vector control mice is provided below. This correction has no effect on the conclusions of the article.
c Intracranial brain tumor xenograft model in nude mice; representative images of tumors from each group are shown. Hematoxylin–eosin (H&E, lower panel magnification, × 100) staining demonstrated that SMC4 overexpression induced the aggressive phenotype of glioma cells in vivo, whereas SMC4 suppression inhibited it.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jiang, L., Zhou, J., Zhong, D. et al. Correction: Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells. Oncogenesis 11, 68 (2022). https://doi.org/10.1038/s41389-022-00442-2
Published:
DOI: https://doi.org/10.1038/s41389-022-00442-2
